Voloridge Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-52,266
| Closed | -$2.9M | – | 1337 |
|
|
2024
Q3 | $2.9M | Buy |
+52,266
| New | +$2.9M | 0.01% | 879 |
|
|
2023
Q3 | – | Sell |
-19,027
| Closed | -$878K | – | 1566 |
|
|
2023
Q2 | $878K | Sell |
19,027
-101,447
| -84% | -$4.68M | ﹤0.01% | 1146 |
|
|
2023
Q1 | $4.83M | Buy |
120,474
+34,640
| +40% | +$1.39M | 0.02% | 679 |
|
|
2022
Q4 | $3.98M | Buy |
85,834
+68,139
| +385% | +$3.16M | 0.02% | 735 |
|
|
2022
Q3 | $733K | Buy |
+17,695
| New | +$733K | ﹤0.01% | 1212 |
|
|
2022
Q2 | – | Sell |
-26,295
| Closed | -$1.91M | – | 1604 |
|
|
2022
Q1 | $1.91M | Sell |
26,295
-21,521
| -45% | -$1.56M | 0.01% | 967 |
|
|
2021
Q4 | $4.02M | Buy |
47,816
+36,062
| +307% | +$3.03M | 0.02% | 796 |
|
|
2021
Q3 | $1.06M | Sell |
11,754
-16,702
| -59% | -$1.51M | 0.01% | 1262 |
|
|
2021
Q2 | $2.71M | Buy |
28,456
+23,854
| +518% | +$2.27M | 0.02% | 872 |
|
|
2021
Q1 | $524K | Sell |
4,602
-6,983
| -60% | -$795K | ﹤0.01% | 1170 |
|
|
2020
Q4 | $1.6M | Buy |
11,585
+904
| +8% | +$125K | 0.01% | 814 |
|
|
2020
Q3 | $878K | Buy |
+10,681
| New | +$878K | 0.01% | 976 |
|
|
2020
Q1 | – | Sell |
-21,635
| Closed | -$924K | – | 1335 |
|
|
2019
Q4 | $924K | Buy |
+21,635
| New | +$924K | 0.02% | 671 |
|
|
2018
Q3 | – | Sell |
-18,470
| Closed | -$1.42M | – | 437 |
|
|
2018
Q2 | $1.42M | Buy |
+18,470
| New | +$1.42M | 0.04% | 294 |
|